|
- IRMS - Nicolae Testemitanu SUMPh
- 1. COLECȚIA INSTITUȚIONALĂ
- MedEspera: International Medical Congress for Students and Young Doctors
- MedEspera 2024
Please use this identifier to cite or link to this item:
http://hdl.handle.net/20.500.12710/28750
Title: | Anti-cancer compounds in brassica vegetables |
Authors: | Ciurea Laura |
Issue Date: | 2024 |
Publisher: | Instituţia Publică Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu” din Republica Moldova |
Citation: | Ciurea Laura. Anti-cancer compounds in brassica vegetables. In: Abstract Book. MedEspera 2024. The 10th International Medical Congress for Students and Young Doctors. 24-27 April 2024, Chișinău, Republic of Moldova, p. 343. ISBN 978-9975-3544-2-4. |
Abstract: | Introduction. Cancer is the main cause of mortality and morbidity worldwide. According to the World Cancer Research Fund an estimated 40% of all human cancers are related to diet. Although a large variety of therapeutic approaches have been developed and translated into clinical protocols, the toxic side effects of cancer treatments negatively impact patients, allowing cancer to grow. Cabbage, broccoli, Brussels sprouts, and other members of the g. Brassica have been widely regarded as potentially cancer preventative. A lower risk of colorectal, cervical, and lung cancers was found to be associated with a high intake of cruciferous vegetables. What differentiates Brassicaceae from other plants is the presence of the secondary metabo lites called glucosinolates, recognized for both their role in plant defense and human health. Aim of study. This review aims to examine the roles of Brassicaceae vegetables and their important bioactive metabolites in prevention and treatment of different cancers. Methods and materials. In order to fulfill the purpose of the study the scientific articles (about 60) from the last decade on Google scholar, Science Direct, PubMed databases were searched by following parameters: Brassicaceae nutrients, compounds, phytochemicals; Brassicaceae in health benefits, cancer prevention and treatment and other. Results. The family Brassicaceae genus Brassica consists of the species Brassica oleracea (e.g., broccoli, cabbage, cauliflower, Brussels sprouts, kale, turnips, collards), which are the most frequently consumed vegetables worldwide. In the last couple of decades, growing scientific evidence has suggested that consumption of cruciferous vegetables has a preventive role against a variety of human diseases. It has been demonstrated that the chemopreventive potential of cruciferous vegetables is likely due to glucosinolates and their secondary metabolites (e.g., isothiocyanates (ITCs)). In vitro and in vivo studies have shown that ITCs are able to activate phase II detoxification enzymes (such as quinone reductase and glutathione S-transferase) as well as to disrupt tubulin polymerization, inducing cell cycle arrest and the activation of apoptosis in cancer cells. Additionally, since dietary ITCs are well absorbed and have good bioavailability, these compounds are promising candidates for anti-cancer therapies. Conclusion. The family Brassicaceae signifies to be an outstanding source of health-promoting phytochemicals and nutrients that would pay beneficial dietary importance against certain types of diseases. Numerous epidemiological studies indicate that Brassica vegetables protect humans against cancer. Thus, Brassica metabolites are emerging as new weapons for anti-cancer therapeutics. World Cancer Research Fund an estimated 40% of all human cancers are related to diet. Although a large variety of therapeutic approaches have been devel oped and translated into clinical protocols, the toxic side effects of cancer treatments ne gatively impact patients, allowing cancer to grow. Cabbage, broccoli, Brussels sprouts, and other m embers of the g. Brassica have been widely regarded as potentially cancer preventative. A lower r isk of colorectal, cervical, and lung cancers was found to be associated with a high intake of cruci ferous vegetables. What differentiates Brassicaceae from other plants is the presence of the secondary metabolites called glucosinolates, recognized for both their role in plant defense and human health. Aim of study. This review aims to examine the roles of Brassicaceae ve getables and their important bioactive metabolites in prevention and treatm ent of different cancers. Methods and materials. In order to fulfill the purpose of the study the scientifi c articles (about 60) from the last decade on Google scholar, Science Direct, PubMed databases were searched by following parameters: Brassicaceae nutrients, compounds, phy tochemicals; Brassicaceae in health benefits, cancer prevention and treatment and other. Results. The family Brassicaceae genus Brassica consists of the species Brassica oleracea (e.g., broccoli, cabbage, cauliflower, Brussels sprouts, kale, tur nips, collards), which are the most frequently consumed vegetables worldwide. In the last couple of decades, growing scientific evidence has suggested that consumption of cruciferous vegetabl es has a preventive role against a variety of human diseases. It has been demonstrated t hat the chemopreventive potential of cruciferous vegetables is likely due to glucosinolates and their secondary metabolites (e.g., isothiocyanates (ITCs)). In vitro and in vivo studies have shown that ITCs are able to activate phase II detoxification enzymes (such as quinone reductase an d glutathione S-transferase) as well as to disrupt tubulin polymerization, inducing cell cycle arrest and the activation of apoptosis in cancer cells. Additionally, since dietary ITCs are well absorbed and have good bioavailability, these compounds are promising candidates for anti-cancer therapies. Conclusion. The family Brassicaceae signifies to be an outstanding so urce of health-promoting phytochemicals and nutrients that would pay beneficial dieta ry importance against certain types of diseases. Numerous epidemiological studies indicate that Br assica vegetables protect humans against cancer. Thus, Brassica metabolites are emergin g as new weapons for anti-cancer therapeutics. |
metadata.dc.relation.ispartof: | MedEspera 2024 |
URI: | https://ibn.idsi.md/collection_view/3104 http://repository.usmf.md/handle/20.500.12710/28750 |
ISBN: | 978-9975-3544-2-4 |
Appears in Collections: | MedEspera 2024
|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
|